Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
04:00:03 2026-11-06 pm EST
|
5-day change | 1st Jan Change | ||
| 102.14 USD | +1.31% |
|
+11.01% | +19.81% |
| Market Cap | 58.73B 52.72B 48.16B 44B 82.97B 5,515B 85.58B 581B 233B 2,944B 220B 216B 9,304B | P/E 2026 * |
43.5x | P/E 2027 * | 31x |
|---|---|---|---|---|---|
| Enterprise Value | 55.19B 49.54B 45.26B 41.35B 77.98B 5,183B 80.42B 546B 219B 2,767B 207B 203B 8,744B | EV / Sales 2026 * |
8.1x | EV / Sales 2027 * | 7.17x |
| Free-Float |
86.64% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Xetra
| EWL | Delayed | |
|
Tradegate
| EWL | Real-time | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +1.31% | ||
| 1 week | +11.01% | ||
| Current month | +11.01% | ||
| 1 month | +18.11% | ||
| 3 months | +14.35% | ||
| 6 months | +22.76% | ||
| Current year | +19.81% |
| 1 week | 87.9 |  | 104.16 |
| 1 month | 82.42 | | 104.16 |
| Current year | 74.66 | | 104.16 |
| 1 year | 74.66 | | 104.16 |
| 3 years | 58.93 | | 104.16 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 2026-05-28 |
| Chief Tech/Sci/R&D Officer | 51 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 9/14/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 9/13/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.31% | +11.01% | +23.90% | +52.22% | 58.73B | |
| +2.63% | -0.32% | +22.75% | +52.69% | 257B | |
| -3.36% | +4.81% | -17.34% | +63.31% | 157B | |
| +1.73% | -0.85% | +9.29% | +17.76% | 162B | |
| -4.23% | +1.83% | -56.84% | -19.05% | 61.96B | |
| -0.76% | +4.13% | +0.84% | -6.12% | 55.42B | |
| -2.05% | -2.95% | +4.30% | +54.85% | 49.18B | |
| +1.73% | -0.06% | +18.49% | +62.52% | 49.27B | |
| +1.00% | -1.11% | +23.29% | +81.48% | 44.96B | |
| -1.64% | +7.59% | +11.07% | +15.88% | 37.25B | |
| Average | -0.36% | +1.98% | +3.97% | +37.55% | 93.31B | |
| Weighted average by Cap. | +0.18% | +1.46% | +5.52% | +40.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.81B 6.11B 5.59B 5.1B 9.62B 640B 9.93B 67.38B 26.97B 342B 25.57B 25.02B 1,079B | 7.48B 6.71B 6.13B 5.6B 10.56B 702B 10.9B 73.97B 29.61B 375B 28.07B 27.47B 1,185B |
| Net income | 1.36B 1.22B 1.12B 1.02B 1.93B 128B 1.99B 13.5B 5.4B 68.4B 5.12B 5.01B 216B | 1.88B 1.69B 1.54B 1.41B 2.66B 177B 2.75B 18.63B 7.46B 94.45B 7.07B 6.92B 298B |
| Net Debt | -3.54B -3.17B -2.9B -2.65B -5B -332B -5.15B -34.97B -14B -177B -13.27B -12.99B -560B | -5.09B -4.57B -4.18B -3.82B -7.2B -478B -7.42B -50.39B -20.17B -255B -19.12B -18.71B -807B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | $102.14 | +1.31% | 5,112,770 |
| 26-11-05 | $100.82 | +1.46% | 9,233,947 |
| 26-11-04 | $99.37 | +4.39% | 7,897,496 |
| 26-11-03 | $95.19 | +2.07% | 6,559,254 |
| 26-11-02 | $93.26 | +1.36% | 12,172,521 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
